In this video interview, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions, highlights FDA’s ...
Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback